EscharEx

DRUG3 trials

Sponsors

Mediwound Ltd., MediWound Ltd

Conditions

Diabetic Lower Extremity UlcersHard to Heal WoundsTraumatic/ Post Operative WoundsVenous Leg Ulcer (VLU)Venous Leg UlcersVenous leg ulcer

Phase 2

Efficacy and Safety Study of EscharEx to Treat (Debride) Hard to Heal Wounds

CompletedNCT02020746

MediWound LtdHard to Heal Wounds, Venous Leg Ulcers, Diabetic Lower Extremity Ulcers +1

Start: 2014-07-24End: 2018-06-04Updated: 2018-08-31

A multicenter, prospective, randomized, placebo and non-surgical standard of care (NSSOC) controlled study, performed to evaluate the safety and efficacy of EscharEx and its placebo (gel vehicle) compared to NSSOC in participants with Venous Leg Ulcers (VLU)

Not yet recruitingCTIS2026-526070-16-00

Mediwound Ltd.Venous Leg Ulcer (VLU)

Target: 35Updated: 2026-09-04

Phase 3

A multicenter, prospective, randomized, double blind, placebo controlled, adaptive design study performed to evaluate the efficacy and the safety of EscharEx in debridement of Venous Leg Ulcers (VALUE)

RecruitingCTIS2024-519623-23-00

Mediwound Ltd.Venous leg ulcer

Start: 2025-10-20Target: 96Updated: 2025-10-20